Kodiak’s KSI-301 Has Narrower Path Forward After Phase II/III Failure In Wet AMD
Executive Summary
Monthly dosing remains a possibility in wet age-related macular degeneration, though diabetic macular edema and retinal vein occlusion look more promising.